Steering Board

Equally representing the sites of Munich, Münster and the Rhine-Main Neuroscience Network (rmn2), the role of the Steering Board is to – amongst other things – coordinate the needs of the individual research groups; examine membership applications; and present project and funding requests to the DFG on behalf of the CRC.

 

Prof. Dr. Heinz Wiendl Univ.-Prof. Prof. h.c. Dr. med. Heinz Wiendl (Münster), Spokesperson
Klinik für Neurologie
Universitätsklinikum der
Westfälischen Wilhelms-Universität Münster
E-Mail: heinz.wiendl@ukmuenster.de

 

 

 

Prof. Dr. Frauke ZippUniv-Prof. Dr. med. Frauke Zipp (rmn2), Co-Spokesperson
Klinik und Poliklinik für Neurologie
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
E-Mail: frauke.zipp@unimedizin-mainz.de

 

 

 

Prof. Martin Kerschensteiner width=Prof. Dr. Martin Kerschensteiner, Secretary
Institut für klinische Neuroimmunologie
Ludwig-Maximilians-Universität München
E-Mail: martin.kerschensteiner@med.uni-muenchen.de

 

 

 

 

Prof. Dr. Thomas Korn Prof. Dr. Thomas Korn
Neurologische Klinik und Poliklinik
Klinikum Rechts der Isar
Technische Universität München
E-Mail: thomas.korn@tum.de

 

 

 

Prof. Lydia Sorokin, PhDUniv.-Prof. Dr. rer. nat. Lydia Sorokin
Institut für Physiologische Chemie und Pathobiochemie
Westfälische Wilhelms-Universität Münster
E-Mail: sorokin@uni-muenster.de

 

 

 

 

Prof. Ari Waisman, PhD Univ.-Prof. Dr. rer. nat. Ari Waisman, PhD
Institut für Molekulare Medizin,
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
E-Mail: waisman@uni-mainz.de

News

Mon, 09/03/2020
Breakthrough: SFB scientsists explain pathomechanism of Susac Syndrome
Münster. Neuroinflammation is often associated with blood-brain-barrier dysfunction, which contributes to neurological tissue damage. In a paper published in the renowned journal Nature Communications SFB 128 scientists from Mueenster reveal the pathophysiology of Susac syndrome (SuS), an enigmatic neuroinflammatory disease with central nervous system (CNS) endotheliopathy. By investigating immune cells from the blood, cerebrospinal fluid, […]...more
Wed, 04/03/2020
The brain is less immune-priviledged than we thought
Münster. Although the CNS is immune privileged, continuous search for pathogens and tumours by immune cells within the CNS is indispensable. Thus, distinct immune-cell populations also cross the blood–brain barrier independently of inflammation/under homeostatic conditions. It was previously shown that effector memory T cells populate healthy CNS parenchyma in humans and, independently, that CCR5-expressing lymphocytes […]...more
Mon, 27/01/2020
Featured Publication: Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis
Münster. Cerebrospinal fluid (CSF) protects the central nervous system (CNS) and analyzing CSF aids the diagnosis of CNS diseases, but our understanding of CSF leukocytes remains superficial. Here, using single cell transcriptomics, SFB researchers identify a specific border-associated composition and transcriptome of CSF leukocytes. In an article published in Nature Communications, they show that multiple […]...more